One platform. Every pathway to market.
The only integrated platform for net revenue performance and integrity.
Solutions
Transforming your approach, starting right where you are
Tell us about your stage in the biopharmaceutical lifecycle and we will show you exactly how IntegriChain drives efficiency and excellence.
From prelaunch contracting strategy and government pricing setup to channel design and patient services infrastructure, we help first time manufacturers reach the market with confidence.
Optimizing rebate and contract performance, maintain pricing compliance, and extract deeper insights from your channel and patient data to protect and grow net revenue for established therapies.
Scale your commercialization infrastructure across new therapeutic categories, markets, and product types with the unified data foundation and expert consulting to enable your evolving business strategy.
Where market access meets proven scale
One trusted partner, from strategic advisors to operational execution.
54%
of Top 50 biopharma trust us
500+
biopharma brands on the ICyte platform
$1T+
gross revenue under management
20+ years
supporting biopharma commercialization and access
ICyte Platform
Biopharmaceutical’s only end-to-end platform.
Net Revenue Management
Precision controls and analytics for gross-to-net management from government pricing to rebate execution. Reduce leakage, improve compliance, and deliver audit-ready results.
Data Aggregation & Insights
Integration of commercial, financial, and operational data to strengthen decision making and profitability by unifying data aggregation, warehousing, master data management, and advanced analytics into a single, end-to-end platform that resolves fragmentation and quality gaps.
Discover the platform powering smarter access and stronger net revenue
Build your career. Make an impact.
Shape the future of healthcare with a team that empowers you to grow.
Testimonials
“We can quickly see all the data in one place and analyze by earned and paid date to understand data lags. We avoid hours and hours of manual data wrangling and reconciliations. Additionally, IntegriChain has reduced that time needed to prepare for a Big-4 audit by more than 50%.”
“Nobody understands the unique drug commercialization requires of a manufacturer tackling rare disease like IntegriChain. Their ability to jump in and function as a seamless adjunct to our commercialization team was critical to our success and the technology and data they bring to the table is essential for our future growth.”
“We were looking for a partner to take our contracts & pricing to a new level of excellence, automation, and fit our changing portfolio. IntegriChain impressed us with their product configurability, commitment to innovation, and deep expertise around the regulatory landscape and interdependencies of our complex drug commercialization processes.”
“Since we began working with IntegriChain, we’ve seen a positive impact in fewer gap days in therapy and lower discontinuation rates by bringing data sets together to look at the patient journey from beginning to end.”